Immunic AG | WebDisclosure

Basculer en Français

10355	Companies
215468	Keywords
145294	Articles
114152	Press releases

Home
Companies
Immunic AG

BRIEF

published on 04/09/2026 at 12:35, 27 days 8 hours ago

Immunic participera à des conférences scientifiques majeures en avril

Biotechnologie Conférences Essais Cliniques Thérapies Orales Neurologie
PRESS RELEASE

published on 04/09/2026 at 12:30, 27 days 8 hours ago

Immunic to Participate in Scientific and Medical Conferences in April
Immunic, Inc. to participate in scientific and medical conferences in April. Presentation on vidofludimus calcium for treating multiple sclerosis at the Neuroimmunology Drug Development Summit and AAN Annual Meeting

Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Scientific Conferences Medical Conferences
BRIEF

published on 04/01/2026 at 12:35, 1 month 5 days ago

Immunic obtient la conformité au Nasdaq

Biotechnologie Marché Boursier Immunitaire Conformité NASDAQ Thérapies Neurologiques
BRIEF

published on 04/01/2026 at 12:35, 1 month 5 days ago

Immunic Achieves Nasdaq Compliance

Biotechnology Nasdaq Compliance Stock Market Immunic Neurologic Therapies
PRESS RELEASE

published on 04/01/2026 at 12:30, 1 month 5 days ago

Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement
Immunic regains compliance with Nasdaq minimum bid price requirement. The company's common stock closed at $1.00 per share or greater for 20 consecutive business days

Compliance Nasdaq Immunic Minimum Bid Price Neurologic Diseases
BRIEF

published on 03/31/2026 at 12:35, 1 month 6 days ago

Immunic Appoints Jon Congleton to Board of Directors

Board Of Directors Biopharmaceutical Multiple Sclerosis Immunic Jon Congleton
BRIEF

published on 03/31/2026 at 12:35, 1 month 6 days ago

Immunic nomme Jon Congleton à son conseil d'administration

Conseil D'administration Biopharmaceutique Sclérose En Plaques Immunitaire Jon Congleton
PRESS RELEASE

published on 03/31/2026 at 12:30, 1 month 6 days ago

Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
Immunic strengthens its Board of Directors with the appointment of seasoned biopharmaceutical executive Jon Congleton on March 31, 2026, to support the development of novel oral therapies for neurologic diseases

Board Of Directors Biopharmaceutical Immunic Neurologic Diseases Jon Congleton
BRIEF

published on 03/10/2026 at 11:35, 1 month 27 days ago

Immunic Secures European Patent for Vidofludimus Calcium Dosing

Intellectual Property Multiple Sclerosis Immunic Vidofludimus Calcium European Patent
BRIEF

published on 03/10/2026 at 11:35, 1 month 27 days ago

Immunic obtient un brevet européen pour le dosage du Vidofludimus Calcium

Propriété Intellectuelle Sclérose En Plaques Vidofludimus Calcium Immunitaire Brevet Européen

Accesswire

Published on 05/06/2026 at 18:35, 2 hours 23 minutes ago

CoTec to Form an Early Stage Exploration Joint Venture with U.S. Company Copper Intelligence to Target Processing Historical Copper Tailings Opportunities in the Democratic Republic of Congo
Published on 05/06/2026 at 16:30, 4 hours 28 minutes ago

Silver Spruce Resources Inc. Announces Results of Annual and Special Meeting of Shareholders
Published on 05/06/2026 at 15:25, 5 hours 33 minutes ago

Electrovaya Announces Date for Q2-2026 Financial Results & Conference Call
Published on 05/06/2026 at 15:15, 5 hours 43 minutes ago

Karbon-X Reports Increased Engagement as Canadian Facilities Reassess Compliance Exposure Ahead of Carbon Deadlines
Published on 05/06/2026 at 15:12, 5 hours 46 minutes ago

Revival Gold Announces Closing of $33 Million Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 05/06/2026 at 20:32, 26 minutes ago

EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 36 minutes ago

EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 1 hour 40 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/06/2026 at 18:47, 2 hours 11 minutes ago

Amadeus Fire Group starts the current year on a positive note and confirms the forecast for the financial year 2026
Published on 05/06/2026 at 18:30, 2 hours 28 minutes ago

Avolta shareholders approve all proposals of the Board at the Ordinary General Meeting 2026

Les Echos

Published on 05/06/2026 at 18:00, 2 hours 58 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 2 hours 58 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 2 hours 58 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 2 hours 58 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 3 hours 13 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30

View all LES ECHOS COMFI WIRE